Planned
Health Pilot
Application typeInnovation Project
Application deadline13 September 2023, 13:00 CEST
Relevant thematic areas for this callHealth
Target groupsPublic sector, Industry
Funding scaleNOK 15 000 000-25 000 000
Amount of funding presumed available for this call for proposalsup to NOK 100 000 000
Project duration24-48 months
Contact for the call
Pilot Helsepilothelse@forskningsradet.no
Download the call
Important dates
02 Aug 2023
Date call is made active
13 Sep 2023
Application submission deadline
01 Jan 2024
Earliest permitted project start
01 Jun 2024
Latest permitted project start
31 May 2028
Latest permitted project completion
Important dates
Purpose
The English version of the call will be published later.
About the call for proposals
The English version of the call will be published later.
Who is eligible to apply?
The English version of the call will be published later.
Who can participate in the project?
The English version of the call will be published later.
What can you seek funding for?
The English version of the call will be published later.
Relevant thematic areas for this call
Health
Health, care and welfare services
Practical information
Assessment criteria
We assess applications in light of the objectives of the application type in question and on the basis of the following criteria:
Excellence
To what extent does the project represent an ambitious innovation that is supported by relevant and high-quality R&D activities?
• To what extent does the innovation represent something novel?
• To what extent will the innovation help to resolve a challenge and/or meet a recognised need in the health services?
• To what extent is the innovation targeted towards new market opportunities for the companies that are partners in the project?
• To what extent does the project build on relevant and updated knowledge?
• To what extent does the project employ relevant and recognised R&D methods?
• To what extent are the R&D activities essential for the success of the innovation?
• To what extent does the innovation represent something novel?
• To what extent will the innovation help to resolve a challenge and/or meet a recognised need in the health services?
• To what extent is the innovation targeted towards new market opportunities for the companies that are partners in the project?
• To what extent does the project build on relevant and updated knowledge?
• To what extent does the project employ relevant and recognised R&D methods?
• To what extent are the R&D activities essential for the success of the innovation?
Implementation
To what extent do the project plan and the project group provide a good basis for implementing the R&D activities and utilising the results?
• To what extent does the R&D project plan incorporate appropriate and effective objectives, work packages, milestones, resources and relevant risk assessments?
• To what extent are the plans for user participation relevant and appropriate?
• To what extent does the project group have the competence and expertise necessary to ensure efficient implementation of the R&D project and with sufficient capacity?
• To what extent is the project strategically aligned with the partners and is the distribution of the budget, roles and responsibilities clearly defined and relevant?
• To what extent does the project manager have relevant expertise and experience to lead an R&D project targeted towards innovation and value creation through public-private collaboration?
• To what extent does the project group have the competence and capacity necessary to ensure utilisation of the R&D results and realisation of the benefits?
• To what extent does the R&D project plan incorporate appropriate and effective objectives, work packages, milestones, resources and relevant risk assessments?
• To what extent are the plans for user participation relevant and appropriate?
• To what extent does the project group have the competence and expertise necessary to ensure efficient implementation of the R&D project and with sufficient capacity?
• To what extent is the project strategically aligned with the partners and is the distribution of the budget, roles and responsibilities clearly defined and relevant?
• To what extent does the project manager have relevant expertise and experience to lead an R&D project targeted towards innovation and value creation through public-private collaboration?
• To what extent does the project group have the competence and capacity necessary to ensure utilisation of the R&D results and realisation of the benefits?
Impact
To what extent does the project pave the way for benefits and value creation in public sector bodies and the Norwegian business sector, and form the basis for other positive impacts in society? To what extent are the potential impacts of the project clearly formulated and plausible?
• To what extent will the project entail a potential for sustainable value creation in the Norwegian business sector with significant economic benefits for companies?
• To what extent will the project form the basis for benefits and value creation in the health sector in the form of more sustainable health and care services?
• To what extent can the project generate other positive external effects for patients, inhabitants and society or in the form of knowledge dissemination?
• To what extent does the plan for implementation of the R&D results and realisation of benefits give reason to indicate that the project can achieve the impacts described? Is the plan relevant and appropriate, for example in relation to
- needs and plans for adapting the organisation, systems and/or work processes;
- needs and plans for investments and allocation of resources;
- management of IPR and regulatory approvals;
- development of business models and/or commercialisation plans incl. partnerships;
- risk assessments in relation to e.g. implementation and/or market access;
- dissemination and communication.
• To what extent will the project entail a potential for sustainable value creation in the Norwegian business sector with significant economic benefits for companies?
• To what extent will the project form the basis for benefits and value creation in the health sector in the form of more sustainable health and care services?
• To what extent can the project generate other positive external effects for patients, inhabitants and society or in the form of knowledge dissemination?
• To what extent does the plan for implementation of the R&D results and realisation of benefits give reason to indicate that the project can achieve the impacts described? Is the plan relevant and appropriate, for example in relation to
- needs and plans for adapting the organisation, systems and/or work processes;
- needs and plans for investments and allocation of resources;
- management of IPR and regulatory approvals;
- development of business models and/or commercialisation plans incl. partnerships;
- risk assessments in relation to e.g. implementation and/or market access;
- dissemination and communication.
Relevance to the call for proposals
To what extent does the project comply with the requirements and guidelines set out in the call?
• To what extent does the application meet the requirements set out in the call and expectations with regard to the Project Owner and partnership constellations?
• To what extent does the application meet the expectations and characteristics of the projects set out in the call?
• To what extent is the project in keeping with thematic priorities set out in the call?
• To what extent does the application meet the requirements set out in the call and expectations with regard to the Project Owner and partnership constellations?
• To what extent does the application meet the expectations and characteristics of the projects set out in the call?
• To what extent is the project in keeping with thematic priorities set out in the call?
Messages at time of print 2 February 2023, 21:44 CET
Important message
For the application deadline 8 February, we manage our hotline +47 22 03 72 00 from Thursday 2 February till Tuesday 7 February at CET 08.00–15.45 and Wednesday 8 February at CET 08.00-13.00.